Prescription Medications, Brand Names Beginning with ‘D’, Page 4

Page 4 of 525 « First Page « … 2 3 4 5 6 … 10 15 20 25 30 … » Last Page »

Dactinomycin

Dactinomycin for injection is an actinomycin indicated for the treatment of: adult and pediatric patients with Wilms tumor, as part of a multi-phase, combination chemotherapy regimen. (1…

X-GEN Pharmaceuticals, Inc.12 November 2019

Dactinomycin

Dactinomycin is an actinomycin indicated for the treatment of: adult and pediatric patients with Wilms tumor, as part of a multi-phase, combination chemotherapy regimen. (1.1) adult and…

Prasco Laboratories11 December 2019

DAKLINZA (Daclatasvir)

DAKLINZA is indicated for use with sofosbuvir, with or without ribavirin, for the treatment of patients with chronic hepatitis C virus (HCV) genotype 1 or genotype 3 infection [ see…

E.R. Squibb & Sons, L.L.C.16 October 2019

Dalbavancin (Anhydrous Dalbavancin)

DALVANCE is indicated for acute bacterial skin and skin structure infections (ABSSSI) caused by designated susceptible strains of Gram-positive microorganisms. (1) To reduce the development of drug-resistant bacteria and maintain the effectiveness…

Durata Therapeutics Inc.5 June 2014

Dalfampridine

Dalfampridine extended-release tablets are indicated as a treatment to improve walking in adult patients with multiple sclerosis (MS). This was demonstrated by an increase in walking…

Mylan Pharmaceuticals Inc.23 July 2018

Page 4 of 525 « First Page « … 2 3 4 5 6 … 10 15 20 25 30 … » Last Page »

FDA Medwatch

Surgical Gowns and Packs by Cardinal Health: FDA Statement – Potential Quality Issues Affecting Some of its Level 3 Surgical Gowns and Accompanying PreSource Procedural Packs
Thu, 16 Jan 2020. The medical device manufacturer Cardinal Health alerted its customers to potential quality issues affecting some of its Level 3 surgical gowns and accompanying PreSource procedural packs.
FUSION IV Pharmaceuticals, Inc dba. AXIA Pharmaceutical Issues Voluntary Nationwide Recall of All Sterile Drug Products Within Expiry Due to A Lack of Assurance of Sterility
Wed, 15 Jan 2020. FUSION IV Pharmaceuticals, Inc dba. AXIA Pharmaceutical is voluntarily recalling all unused sterile drug products within expiry, to the user level, due to a lack of assurance of sterility. The recalled sterile products have been found to be…

RxDrugLabels

Medication Sections

Medication Information by RSS

About

As a leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. RxDrugLabels.com provides the full prescription-only subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.